论文部分内容阅读
女性生殖器恶性肿瘤严重威胁着妇女的健康,目前化疗多根据动物试验及积累的临床经验选用化疗药物。恶性肿瘤类型繁多,生物学特性不同,对化疗药物的反应又有显著的个体差异,因此,在治疗上有一定的盲目性。妇科恶性肿瘤多采用综合治疗,化疗是重要的治疗手段之一。恶性肿瘤的临床疗效除与化疗药物有关外,还取决于机体对化疗药物的敏感性。因此,近年来除积极寻找新的抗肿瘤药物外,进行化疗药物敏感试验,是提高临床疗效的新途径。目前药敏试验方法及临床应用尚处于摸索阶段,各家报道不一,但一般药敏试验结果与临床治疗过
Female genital malignancies pose a serious threat to the health of women. At present, chemotherapeutic drugs are mostly used according to animal experiments and accumulated clinical experience. The variety of malignant tumors, different biological characteristics, the response to chemotherapy drugs have significant individual differences, therefore, there is a certain degree of blindness in the treatment. Gynecological malignancies use more comprehensive treatment, chemotherapy is an important means of treatment. In addition to the clinical efficacy of malignant tumors and chemotherapy drugs, but also depends on the body’s sensitivity to chemotherapy drugs. Therefore, in addition to actively looking for new antitumor drugs in recent years, conducting chemosensitivity tests is a new way to improve clinical efficacy. At present drug susceptibility test methods and clinical applications are still in the groping phase, various reports vary, but the general susceptibility test results and clinical treatment